Anti-alpha-synuclein antibodies and uses thereof
US12049493B2 · kind B2 · utility
0Cited by
29References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2018 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Oct 27, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2835
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure discloses anti α-Syn antibodies preferentially recognizing α-Syn aggregates. The antibodies of the present invention bind to α-Syn aggregates with high affinity and specificity and inhibit accumulation or intercellular transfer of α-Syn aggregates, and thus can be used for detection, diagnosis and/or treatment or prevention of various diseases caused by the accumulation of α-Syn aggregates.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.